Latest in Pfizer Pins
Sort by
18 items
-
Pfizer's Hympavzi Approved for Treatment of Certain Types of Hemophilia
The FDA approved Pfizer’s Hympavzi, which can be an alternative to intravenous infusions often administered multiple times a week.Business - The Wall Street Journal - October 11 -
Starboard-Pfizer battle strains Guggenheim’s relationship with drugmaker
Boutique adviser’s work for two former executives has threatened its lucrative ties to the vaccine makerBusiness - Financial Times - October 15 -
Starboard calls for Pfizer board to ‘hold management accountable’
Jeff Smith tells activist investor conference that pharma group’s recent returns are ‘not adequate’Business - Financial Times - October 22 -
Pfizer’s earnings crush estimates as company raises guidance
Drug company Pfizer saw strong growth for its heart-disease drugs and migraine treatment.Business - MarketWatch - October 29 -
Pfizer’s guidance bump will not heal deeper wounds
Starboard is right to take drugmaker to task for bingeing on overpriced dealsBusiness - Financial Times - October 29 -
Pfizer's Strong Quarter Bolsters CEO's Comeback Efforts
The pharmaceutical company reported its third consecutive quarter with positive results.Business - The Wall Street Journal - October 29 -
Chinese Growth Comes in Cooler as Investors Pin Hopes on Stimulus
Wobbly data for the third quarter underscores challenges for Beijing policymakers seeking to boost economic activity.World - The Wall Street Journal - October 18 -
Kamala Harris yet to speak as Trump wins White House
Exit poll data suggests Kamala Harris may have underperformed with female voters.Top stories - BBC News - 2 days ago -
Jeff Smith, the activist picking a fight with Covid hero Pfizer
Widely feared boss of Starboard Value often befriends the corporate leaders he is targetingBusiness - Financial Times - October 25 -
How are investors preparing for the Budget?
Executives are seeking to minimise their exposure ahead of what could be the biggest tax-raising statement for a generationBusiness - Financial Times - October 29 -
Pfizer CEO defends performance after Starboard activist criticism
Drugmaker boosts full-year sales and profit forecasts after reporting better than expected earningsBusiness - Financial Times - October 29 -
Pink postpones slate of Midwest concerts, pinning pause on 'reasons beyond my control'
Pink reassures fans that her team is working to reschedule a handful of shows in the Midwest after postponing them for 'reasons beyond my control.'Entertainment - Los Angeles Times - October 21 -
GOP rep gives Trump 'french fries certification pin' during stop in storm-ravaged NC town
North Carolina Rep. Chuck Edwards (R) gave former President Trump a "french fries certification pin" honoring the former president's appearance working the drive-thru at a McDonald's over the ...Politics - The Hill - October 22 -
NFL punt of the year? Jaguars' Logan Cooke booms 73-yarder that pins Packers at their 2-yard line
The Jaguars punter had what could be the punt of the year, booming a 73-yard kick that pinned the Packers back at their 2-yard line.Sports - Yahoo Sports - October 27 -
Mario & Luigi: Brothership Preorders - Get An Exclusive Pin Set At Best Buy Before It's Gone
Mario & Luigi: Brothership Physical Edition ...Tech - GameSpot - 2 days ago -
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
It is a critical quarterly report for Pfizer, which is grappling with activist pressure from Starboard Value.Business - CNBC - October 29 -
Pfizer CEO says he welcomes good ideas as Starboard ups pressure on company
Pfizer reported an earnings beat Tuesday morning and raised its full-year outlook, seeing strength in sales of its Covid vaccine and antiviral pill, Paxlovid.Business - CNBC - October 29